Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025
Operating expenses:
Research and development	$ 11,429	$ 6,969	$ 37,459	$ 21,935
General and administrative	2,487	1,744	7,475	6,002
Total operating expenses	13,916	8,713	44,934	27,937
Loss from operations	(13,916)	(8,713)	(44,934)	(27,937)
Interest income	768	853	2,523	2,421
Other expense, net	(3)	0	(6)	(66)
Total other income, net	765	853	2,517	2,355
Loss before provision for income taxes	(13,151)	(7,860)	(42,417)	(25,582)
Provision for income taxes	88	0	130	0
Net loss	$ (13,239)	$ (7,860)	$ (42,547)	$ (25,582)
Net loss per share attributable to common stockholders, basic	$ (10.06)	$ (7.58)	$ (34.02)	$ (24.89)
Net loss per share attributable to common stockholders, diluted	$ (10.06)	$ (7.58)	$ (34.02)	$ (24.89)
Weighted-average shares outstanding, basic	1,315,428	1,037,449	1,250,617	1,027,901
Weighted-average shares outstanding, diluted	1,315,428	1,037,449	1,250,617	1,027,901
Comprehensive loss:
Net loss	$ (13,239)	$ (7,860)	$ (42,547)	$ (25,582)
Unrealized (loss) gain on marketable securities	(3)	30	(168)	19
Comprehensive loss	$ (13,242)	$ (7,830)	$ (42,715)	$ (25,563)